The Australian Government’s recent decision to revoke a 5% tariff concession order (TCO) on the importation of acetate frames from Europe has caused concern
Optometrists are invited to attend a full day conference on Myopia Progression in Children (MPIC) on Saturday 3 September.
Opthea will advance ongoing Phase 3 clinical trials and pre-commercialisation activities of OPT-302 for wet age-related macular degeneration (wet AMD) following a non-dilutive financing
Optical dispensers, optical assistants, and industry colleagues are invited to attend a full day event of discussions, lectures and practical sessions facilitated by industry
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
